Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study"

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study"

[...]before making any conclusions on this issue, additional multinational or multiethnic cohort studies are required. In an analysis of the Korean National Health Insurance Service data, mortality related to HCC decreased, whereas mortality related to EHM increased in the antiviral era [13]. Yewan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and molecular hepatology 2024, 30(4), , pp.718-720
Hauptverfasser: Park, Yewan, Sinn, Dong Hyun
Format: Artikel
Sprache:eng
Schlagworte:
antiviral drug
Antiviral drugs
Breast cancer
Cancer therapies
chronic hepatitis b
Clinical medicine
Cohort analysis
Drug resistance
Hepatitis B
Hepatology
Infections
Liver cancer
Liver cirrhosis
Lymphoma
Mortality
Systematic review
tumor
Viral infections
내과학
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]before making any conclusions on this issue, additional multinational or multiethnic cohort studies are required. In an analysis of the Korean National Health Insurance Service data, mortality related to HCC decreased, whereas mortality related to EHM increased in the antiviral era [13]. Yewan Park Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea Dong Hyun Sinn Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
ISSN:2287-2728
2287-285X
2287-285X
DOI:10.3350/cmh.2024.0519